Summary
A methodology based on molecular modeling and chemometrics is applied to identify the geometrical pharmacophore and the stereoelectronic requirements for the activity in a series of inhibitors of 3-hydroxy 3-methylglutaryl coenzyme A (HMG-CoA) reductase, an enzyme involved in cholesterol biosynthesis. These inhibitors present two common structural features—a 3,5-dihydroxy heptanoic acid which mimics the active portion of the natural substrate HMG-CoA and a lipophilic region which carries both polar and bulky groups. A total of 432 minimum energy conformations of 11 homologous compounds showing different levels of biological activity are calculated by the molecular mechanics MM2 method. Five atoms are selected as representatives of the relevant fragments of these compounds and three interatomic distances, selected among 10 by means of a Principal Component Analysis (PCA), are used to describe the three-dimensional disposition of these atoms. A cluster analysis procedure, performed on the whole set of conformations described by these three distances, allows the selection of one cluster whose centroid represents a geometrical model for the HMG-CoA reductase pharmacophore and the conformations included are candidates as binding conformations. To obtain a refinement of the geometrical model and to have a better insight into the requirements for the activity of these inhibitors, the Molecular Electrostatic Potential (MEP) distributions are determined by the MNDO semiempirical method.
Similar content being viewed by others
References
Mayer, D., Naylor, C.B., Motoc, I. and Marshall, G.R., J. Comput.-Aided Mol. Design, 1 (1987) 3.
Crippen, G.M. and Havel, T.F., Distance Geometry and Molecular Conformation, Research Studies Press, Tauton, U.K., John Wiley and Sons, New York, 1988, p. 541.
J.Tomasi, In Ratajczak, H. and Orville-Thomas, W.J. (Eds), Molecular Interactions, Vol. 3, John Wiley and Sons, New York, 1982, pp. 119–182.
Burt, C., Richards, W.G. and Huxley, P., J. Comp. Chem., 11, (1990) 1139.
Manaut, F., Sanz, F., José, J. and Milesi, M., J. Comput.-Aided Mol. Design, 5 (1991) 371.
Stokker, G.E., Alberts, A.W., Anderson, P.S., Cragoe, E.J., Deana, A.A., Gilfillan, J.L., Hirshfield, J., Holtz, W.J., Hoffman, W.F., Huff, J.W., Lee, T.J., Novello, F.C., Prugh, J.D., Rooney, C.S., Smith, R.L. and Willard, A.K., J. Med. Chem., 29 (1986) 170.
Kathawala, F.G., In Van derGoot, H., Domány, G., Pallos, L. and Timmerman, H. (Eds), Trends in Medicinal Chemistry '88, Elsevier Science Publishers, Amsterdam, 1989, pp. 709–728.
Stokker, G.E., Hoffman, W.F., Alberts, A.W., Cragoe, E.J., Deana, A.A., Gilfillan, J.L., Huff, J.W., Novello, F.C., Prugh, J.D., Smith, R.L. and Willard, A.K., J. Med. Chem., 28 (1985) 347.
Baader, E., Bartmann, W., Beck, G., Bergmann, A., Jendralla, H., Kesseler, K., Wess, G., Schubert, W., Granzer, E., Kerekjarto, B.V. and Krause, R., Tetrahedron Lett., 29 (1988) 929.
Beck, G., Kesseler, K., Baader, E., Bartmann, W., Bergmann, A., Granzer, E., Jendralla, H., Kerekjarto, B.V., Krause, R., Paulus, E., Schubert, W. and Wess, G., J. Med. Chem., 33 (1990) 52.
Stokker, G.E., Alberts, A.W., Gilfillan, J.L., Huff, J.W. and Smith, R.L., J. Med. Chem., 29 (1986) 852.
Hoffman, W.F., Alberts, A.W., Cragoe, E.J., Deana, A.A., Evans, B.E., Gilfillan, J.L., Gould, N.P., Huff, J.W., Novello, F.C., Prugh, J.D., Rittle, K.E., Smith, R.L., Stokker, G.E. and Willard, A.K., J. Med. Chem., 29 (1986) 159.
Roth, B.D., Ortwine, D.F., Hoefle, M.L., Stratton, C.D., Sliskovic, D.R., Wilson, M.W. and Newton, R.S., J. Med. Chem. 33 (1990) 21.
Sit, S.Y., Parker, R.A., Motoc, I., Han, W., Balasubramanian, N., Catt, J.D., Brown, P.J., Harte, W.E., Thompson, M.D. and Wright, J.J., J. Med. Chem., 33 (1990) 2982.
Cosentino, U., Moro, G., Pitea, D., Todeschini, R., Brossa, S., Gualandi, F., Scolastico, C. and Giannessi, F., Quant. Struct.-Act Relat., 9 (1990) 195.
Belvisi, L., Brossa, S., Salimbeni, A., Scolastico, C. and Todeschini, R., In Silipo, C. and Vittoria, A. (Eds) QSAR: Rational Approaches to the Design of Bioactive Compounds, Elsevier Science Publishers, Amsterdam, 1991, pp. 423–426.
Mohamadi, F., Richards, N.G.J., Guida, W.G., Liskamp, R., Lipton, M., Caufield, C., Chang, G., Hendrickson, T. and Still, W.C., J. Comput. Chem., 11 (1990) 440.
SYBYL Molecular Modeling Software, Tripos Associates/Evans & Sutherland, St. Louis, MO, U.S.A.
Wold, S., Esbensen, K. and Geladi, P., Chemometrics Int. Lab. Syst., 2 (1987) 37.
Jarvis, R.A. and Patrick, E.A., IEEE Trans. Comput., C 22 (1973) 1025.
SCAN, by Todeschini, R., Frank, I.E., Moro, G. and Cosentino, U., JeryIl Inc., 790 Esplanada, Stanford, CA 94305, U.S.A.
MOPAC 5.0 ESP: Merz, K.M. and Besler, B.H., QCPE Bull., 10 (1990) 589.
Luque, F.J., Illas, F. and Orozco, M., J. Comput. Chem., 11 (1990) 416.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cosentino, U., Moro, G., Pitea, D. et al. Pharmacophore identification by molecular modeling and chemometrics: The case of HMG-CoA reductase inhibitors. J Computer-Aided Mol Des 6, 47–60 (1992). https://doi.org/10.1007/BF00124386
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00124386